Brief: NextCell To Present Status Of Ongoing Clinical Trial At Nordic Life Science Days
11/09/2018 07:55
Sept 11 (Reuters) - NextCell Pharma AB NXTCL.TE :
* NEXTCELL TO PRESENT STATUS OF ONGOING CLINICAL TRIAL AT
THE
NORDIC LIFE SCIENCE DAYS
* SO FAR THERE HAVE BEEN NO ADVERSE REACTIONS SUSPECTED TO
BE
RELATED TO TREATMENT
Source text for Eikon: ID:nWkr8JXD9
Further company coverage: NXTCL.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln